Single-dose azithromycin to treat latent yaws
Main Authors: | Michael Marks, David Mabey |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2017-12-01
|
Series: | The Lancet Global Health |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2214109X17304242 |
Similar Items
-
Effectiveness of single-dose azithromycin to treat latent yaws: a longitudinal comparative cohort study
by: Oriol Mitjà, DrMD, et al.
Published: (2017-12-01) -
Prevalence of Active and Latent Yaws in the Solomon Islands 18 Months after Azithromycin Mass Drug Administration for Trachoma.
by: Michael Marks, et al.
Published: (2016-08-01) -
Low-dose versus standard-dose azithromycin for treatment of yaws
by: Lenka Mikalová, et al.
Published: (2018-04-01) -
Towards eradication of yaws disease by 2020 using a single dose of azithromycin in mass treatment
by: C.R. Revankar, et al.
Published: (2014-04-01) -
Failure of PCR to Detect Treponema pallidum ssp. pertenue DNA in Blood in Latent Yaws.
by: Michael Marks, et al.
Published: (2015-01-01)